#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15906	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2286	693.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1557	1557	C	910	C	863	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28550	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3473	818.7	0	.	n	.	0	T695C	SNP	695	695	T	1009	1009	C	843	C,T	796,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28550	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3473	818.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1651	1651	A	933	A,G	881,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28550	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3473	818.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2285	2285	C	929	C	864	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28550	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3473	818.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2359	2359	A	954	A	906	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28550	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3473	818.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2911	2911	C	835	C,T	790,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2200	folP	852	852	100.0	folP.l15.c4.ctg.1	1665	131.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1077	1079	AGC	236;238;237	A,C;G;C,A	228,1;230;225,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5550	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3367	164.4	1	SNP	p	S91F	0	.	.	271	273	TCC	599	601	TCC	224;224;225	T;C;C	205;202;202	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5550	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3367	164.4	1	SNP	p	D95G	0	.	.	283	285	GAC	611	613	GAC	229;226;227	G;A;C	209;204;206	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5550	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3367	164.4	1	SNP	p	D95N	0	.	.	283	285	GAC	611	613	GAC	229;226;227	G;A;C	209;204;206	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1678	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1471	113.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	430	432	ACC	177;174;175	A;C;C	158;170;170	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1678	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1471	113.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	445	447	CAC	168;169;169	C;A;C	153;151;158	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1678	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1471	113.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	628	630	CAC	207;206;209	C;A;C	198;195;199	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1678	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1471	113.6	1	SNP	p	G45D	0	.	.	133	135	GGC	448	450	GGC	167;168;167	G;G;C	157;156;156	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	972	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	972	99.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5380	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2975	180.1	1	SNP	p	D86N	0	.	.	256	258	GAC	597	599	GAC	212;214;215	G;A;C,G	200;195;203,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5380	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2975	180.1	1	SNP	p	S87W	0	.	.	259	261	AGT	600	602	AGT	217;216;217	A;G;T	205;206;201	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5380	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2975	180.1	1	SNP	p	S87I	0	.	.	259	261	AGT	600	602	AGT	217;216;217	A;G;T	205;206;201	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5380	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2975	180.1	1	SNP	p	S87R	0	.	.	259	261	AGT	600	602	AGT	217;216;217	A;G;T	205;206;201	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5380	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2975	180.1	1	SNP	p	S88P	0	.	.	262	264	TCC	603	605	TCC	216;216;217	T;C;C	206;201;203	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4666	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2652	175.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1545	1547	GGC	236;234;231	G;G;C	217;216;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1337	1339	GCA	219;223;225	G;C;A	213;215;217	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1340	1342	ATC	226;226;232	A;T;C	219;218;224	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1352	1354	GTG	232;234;235	G,A;T;G	221,1;225;226	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1352	1354	GTG	232;234;235	G,A;T;G	221,1;225;226	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1856	1858	ACC	202;203;206	A;C;C	188;190;193	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1910	1912	GCG	191;193;191	G;C,G;G	170;152,2;159	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1910	1912	GCG	191;193;191	G;C,G;G	170;152,2;159	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2033	2035	GGC	190;189;187	G;G;C	174;173;170	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2042	2044	GGC	180;180;180	G;G;C	160;163;162	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4186	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2476	168.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2060	2062	CCG	148;148;146	C,G;C;G	111,3;115;110	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5858	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3196	182.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1622	1624	CTG	202;201;202	C;T;G	184;183;188	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2416	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1873	128.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	174	C	156	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	485	487	GGA	213;212;217	G;G;A	199;199;202	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	0	.	p	.	0	F135L	NONSYN	403	405	TTT	746	748	CTT	211;210;213	C,G;T;T,G	196,1;196;199,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	0	.	p	.	0	R143G	NONSYN	427	429	AGA	770	772	GGA	219;215;215	G,C;G,A;A	201,1;194,2;191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	0	.	p	.	0	D171G	NONSYN	511	513	GAT	854	856	GGT	233;236;238	G;G;T	220;222;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	0	.	p	.	0	G189S	NONSYN	565	567	GGC	908	910	AGC	247;247;247	A;G;C	233;232;232	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	974	974	T	218	T	207	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	1	SNP	p	G120K	0	.	.	358	360	GGT	701	703	GGT	213;211;215	G,C;G;T,C	200,1;202;200,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	1	SNP	p	A121N	0	.	.	361	363	GCC	704	706	GCC	216;216;218	G;C;C	201;207;210	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2708	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1539	174.8	1	SNP	p	A121D	0	.	.	361	363	GCC	704	706	GCC	216;216;218	G;C;C	201;207;210	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10998	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4926	222.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2024	2026	AAT	236;240;239	A;A;T	225;230;228	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1166	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1102	105.2	1	SNP	p	V57M	1	.	.	169	171	ATG	529	531	ATG	229;228;227	A;T;G	213;212;212	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
